Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation.
Christoph WelschAnna Katharina FlügelSusanne RondotEgbert SchulzeIshani SircarJudith NußbaumerJörg BojungaPublished in: BMC endocrine disorders (2022)
We report a novel heterozygous MEN1 frameshift mutation, potentially causing (at least partial) inactivation of menin tumor suppression potential but lacking a genotype-phenotype correlation. Our study highlights the importance of personalized care with appropriate testing and counseling in MEN1 families.